+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Anti-enolase-alpha autoantibodies in cancer-associated retinopathy: epitope mapping and cytotoxicity on retinal cells



Anti-enolase-alpha autoantibodies in cancer-associated retinopathy: epitope mapping and cytotoxicity on retinal cells



Journal of Autoimmunity 11(6): 671-677



Patients with cancer-associated retinopathy syndrome (CAR), a progressive blinding disease related to retinal degeneration and systemic tumor outside the eye, develop autoantibodies against alpha-enolase. A small percentage of healthy subjects without evident tumor or visual symptoms also possess autoantibody against enolase. In these studies we examined the fine specificity of anti-enolase antibodies derived from patients with CAR and healthy individuals, using synthetic peptides covering the entire sequence of human alpha-enolase. Epitope mapping revealed that three binding regions of enolase within the residues 31-38 (FRAAVPSG), 176-183 (ANFREAMR), and 421-428 (AKFAGRNF) were common for all autoantibodies tested. However, pathogenic sera recognized an additional unique region, the sequence 56-63 (RYMGKGVS). There were also differences in in vitro cytotoxic activities on E1A.NR3 retinal cells and cell-death promoting activities between anti-enolase antibodies of healthy and CAR affected individuals. These studies showed that anti-enolase antibodies from patients with CAR were able to induce apoptotic cell death in E1A.NR3 retinal cells and provided a potential mechanism for retinal degeneration in humans.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 045269302

Download citation: RISBibTeXText

PMID: 9878089

DOI: 10.1006/jaut.1998.0239


Related references

Cellular targets of anti-alpha-enolase autoantibodies of patients with autoimmune retinopathy. Journal of Autoimmunity 23(2): 161-167, 2004

The role of anti-alpha-enolase autoantibodies in pathogenicity of autoimmune-mediated retinopathy. Journal of Clinical Immunology 27(2): 181-192, 2007

Cloning of enolase isoenzymes from human retina for autoantigen characterisation and epitope mapping in patients with cancer associated retinopathy. Investigative Ophthalmology & Visual Science 36(4): S490, 1995

Cytotoxic effect of anti-recoverin and anti-enolase autoantibodies on retinal cells. Journal of Allergy & Clinical Immunology 99(1 Part 2): S20, 1997

Anti-alpha-enolase autoantibodies are down-regulated in advanced cancer patients. Japanese Journal of Clinical Oncology 40(7): 663-669, 2010

Significance of Anti-retinal Autoantibodies in Cancer-associated Retinopathy with Gynecological Cancers. Journal of Clinical and Experimental Ophthalmology 4(6): 307, 2013

Characterization of naturally occurring autoantibodies against tumour necrosis factor-alpha (TNF-alpha): in vitro function and precise epitope mapping by phage epitope library. Clinical and Experimental Immunology 98(3): 520-525, 1994

Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung. American Journal of Ophthalmology 139(4): 746-747, 2005

The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy. Clinical Immunology & Immunopathology 78(2): 120-129, 1996

Anti-NH2-terminal of alpha-enolase (NAE) autoantibodies. Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl. 6): 648-650, 2010

Characteristics of anti-retinal autoantibodies in patients with autoimmune retinopathy. IOVS 42(4): S570, 2001

A unique case of autoimmune retinopathy associated with anti-alpha-enolase antibodies. Case Reports in Ophthalmological Medicine 2011: 371324, 2011

Epitope mapping of naturally occurring anti-hY5 Ro RNA autoantibodies in human sera. Arthritis & Rheumatism 35(9 Suppl. ): S62, 1992

Epitope mapping of naturally occurring anti-hY5 Ro RN autoantibodies in human sera. Journal of Immunology 150(8 Part 2): 18A, 1993

Anti-mitochondrial flavoprotein autoantibodies of patients with myocarditis and dilated cardiomyopathy (anti-M7): Interaction with flavin-carrying proteins, effect of vitamin B2 and epitope mapping. Clinical and Experimental Immunology 115(3): 404-408, 1999